Microhealth is the world’s leading digital hematology platform.

We were founded in 2011 by a patient and a medical researcher at Columbia University to improve remote access and health outcomes for patients with bleeding disorders. Today, we cover over 33% of US hemophilia patients and 50% of hemophilia treatment centers as the easiest, safest way to log their medications, track symptoms, and optimize treatment.

Our digital ecosystem spans the entire healthcare value chain, including patients and caregivers, healthcare providers and clinics, pharmaceutical companies, and researchers. With treatments costing $300K+ per patient per year, we have a significant opportunity to improve care for all stakeholders.